• Perrigo Company (PRGO) Receives FDA Approval and Commences Launch of Clindamycin Phosphate and Benzoyl Peroxide 1.2% / 5% Gel More...

• Eli Lilly and Company (LLY) Statement on PDUFA Vote by Senate More...

• Medivation, Inc. (MDVN) Says Astellas Pharma Inc. (YPH.BE) Submits MAA to European Medicines Agency for Enzalutamide More...

• XOMA (US) LLC (XOMA) Initiates Phase 3 Gevokizumab Trial in Patients With Non-Infectious Uveitis and Phase 2 Gevokizumab Trial in Patients With Erosive Osteoarthritis More...

• Amicus Therapeutics, Inc. (FOLD) Reports Positive Preliminary Results for AT2220 More...

• Topica Pharmaceuticals Initiates Phase 2b/3 Study of Luliconazole in Patients With Onychomycosis of the Toenails More...

• GlobeImmune, Inc.'s GI-4000 in Combination With Gemcitabine Following Surgery Shows Evidence of an Improvement in Survival in a Phase 2b Clinical Trial With Ras Mutation Positive Pancreas Cancer More...

• Derma Sciences, Inc. (DSCI) Announces Publication of DSC127 Phase 2 Trial Results in Wound Repair and Regeneration More...

• Low-Fat Diet After Weight Loss May Raise Risk of Gain, Boston Children's Hospital Study More...

• Coffee in Moderation May Benefit Heart Slightly, Harvard University and Beth Israel Deaconess Medical Center Study More...

• Long-Term Calcium and Vitamin D Supplement Use May Be Linked to Increased Risk of Kidney Stones More...

• Facebook Makes Us Feel Good About Ourselves, University of Georgia Study More...

• Monitored Vitamin D Therapy Safe for Patients With High Blood Calcium LevelsMore...

• Rockwell Medical Technologies (RMTI) Announces Canadian Patent Issuance for Proprietary SFP-Iron Delivery More...

• Nevro Corp. Announces Issuance of Key U.S. Patents for Innovative Chronic Pain Treatment More...

• Octapharma USA, Inc. Expands Access to octagam® 5% for Participating 340B Healthcare Facilities More...

• Covance Inc. (CVD) Expands; Company to Add 465 Jobs to Indiana Site More...

• Merck & Co., Inc. (MRK) Plans to Cut 30 Jobs at Cherokee More...

• Metro Mold and Design Invests in Jobs and Growth With New Facility More...

• Merck & Co., Inc. (MRK), AstraZeneca PLC (AZN) Venture Stays Intact for at Least Two More Years More...

• Sinopharm, Fosun Pharma, China Meheco Corporation Join to Form $157 Million PE Fund More... 

• BioDiem Ltd. (BDM.AX) Acquires Rights to Novel Hepatitis Vaccine Technology from University of Canberra More...

• Soligenix (SNGX.OB) Announces Collaboration with Infectious Disease Research Institute (IDRI) to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants More...

• New England Biolabs, Inc. Demonstrates Support for Interactive Scientific Literature by Collaborating with AQnowledge More...

• Cornerstone Therapeutics Inc. Completes Acquisition of EKR Therapeutics, Inc. More...

• Imaxio Boosts Genomics Capacity With New Automated Equipment More...

• EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region More...

• Alnylam Pharmaceuticals (ALNY) Expands and Develops Management Team More...

• Kedem Pharmaceuticals (KDMP.OB) to Appoint New Chief Operating Officer More...

• BioMotiv Launches Novel Drug Development Operation, Names Leadership Team More...

• Anavex Life Sciences Corp. (AVXL.OB) Appoints Robert Chisholm as CFO More...

• Abbott Laboratories (ABT) Hosts Conference Call for Second-Quarter Earnings More...

• Kewaunee Scientific Corporation Reports Significantly Improved Results for Fourth Quarter More...

• Merck & Co., Inc. (MRK) to Hold Second-Quarter 2012 Sales and Earnings Conference Call on July 27 More...

• Perrigo Company (PRGO) to Invest $40 Million to Expand in Negev Plants More...